Latest Breaking News On - Refills exceed - Page 1 : comparemela.com

Phase 3 Pivotal Study of PL9643 in Patients with Dry Eye Disease Ongoing Positive Interim Analysis – DMC Recommended Study Size of 350 patients Topline Results.

United statesCarl spanaPalatin technologies incPrnewswire palatin technologies incSecurities exchangeDry eye disease ongoingInterim analysisStudy sizeProduct revenue increasedPrescriptions dispensed increasedRefills exceedTotal prescriptionsUlcerative colitis commencedInterim analysis first quarter calendarCurrently expectedThird quarter calendar